Spontaneous Bilateral Subdural Hematoma in a Falciparum Malaria patient: Case report

Written By :  Hina Zahid
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-07-20 08:00 GMT   |   Update On 2020-07-20 10:02 GMT
Advertisement

Dr S C Chaudhary at departments of Medicine, CSM Medical University, Lucknow, Uttar Pradesh and colleagues have reported a rare  case of P. falciparum malaria associated with unusual subdural hematoma (SDH) and thrombocytopenia that recovered without surgical intervention. The case has been published in the Journal of Physicians of India.

A 70-year old female presented with complaints of fever with chills, headache for 15 days and altered sensorium for 7 days. Peripheral blood smear showed ring form of P. falciparum and CT brain revealed bilateral subdural hematoma. Patient received Artesunate based combination therapy and recovered completely without surgical intervention within 8 days of admission.

Advertisement

Malaria is a protozoan disease transmitted by the bite of infected Anopheles mosquitoes. The most important of parasi t ic disease of humans. India, along with Ethiopia, Pakistan and Indonesia accounts for 80% of all malarial cases worldwide. Infections with plasmodium falciparum and plasmodium vivax are the most prevalent.

A 70-year old female presented with complaints of fever, chills, headache for 15 days and altered sensorium for 7 days was admitted to MBGH, Udaipur. There was no rash, petechiae or bleeding observed. There was hepatosplenomegaly on systemic examination. PBF smears showed a severe degree of thrombocytopenia (8000/microL). Detailed Microscopic Examination of Giemsa stained thin and thick PBF smears revealed infested RBC with ring form of P.falciparum. Serum analysis for liver function revealed elevated levels of total bilirubin (2.4 mg/dl), direct bilirubin (1.65 mg/ dl), AST (85 U/L) and ALT (312 U/L). Serology for HIV, Salmonella and Dengue infections were negative. The patient was given parenteral Artesunate (2.4 mg/kg stat iv followed by 2.4 mg/kg at 12 and 24 h and then daily for 6 days) and parenteral clindamycin (10 mg/kg iv BD for 7 days). NCCT brain was done to rule out the cause of headache and altered sensorium. It revealed bilateral SDH (Figure 1). Neurosurgeon advised to manage the patient conservatively. Our patient improved completely with ACT regime. Patient became fully conscious and oriented within 5 days of admission and recovered completely.

She was discharged from the hospital in good clinical condition without any surgical intervention.


As per WHO proposed definition the features of severe malaria includes cerebral malaria, pulmonary oedema, circulatory collapse, DIC, anemia and hepatitis. Unusual complication such as bilateral SDH is extremely rare and has been reported only in few cases like in falciparum malaria3,4 or with cerebral malaria. Our case is being reported to emphasize the occurrence and amalgamation of severe clinical manifestation in p. falciparum. It is likely that the occurrence of SDH in this case is a secondary complication to thrombocytopenia.

An intrusive approach is required in diagnosing and recognizing multiple complications, which provides a complete and reliable picture of s e vere plasmodi u m i n f e c t i o n s allowing appropriate treatment and management.

www.japi.org


Tags:    
Article Source : Journal of the Association of Physician of India

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News